Abstract
Mitochondria produce the majority of cellular energy via the “slow burn” of substrates such as glucose, free fatty acids and ketones. In diabetes, altered mitochondrial energetics and substrate utilisation may explain, in part, an organ’s susceptibility to complications. This is particularly evident at sites such as the kidney, heart, neurons and retina, which have high energy demands and oxygen consumption rates to meet functional requirements. Within this review we highlight the recent research implicating mitochondrial dysfunction, with particular focus on the contribution of mitochondrial reactive oxygen species, on the development and progression of diabetes complications. Finally, we discuss the current strategies which are being assessed to combat mitochondrial dysfunction in diabetes complications.
Keywords: Diabetic complications, mitochondria, nephropathy, networking, oxidative phosphorylation, retinopathy, ROS, superoxide.
Graphical Abstract
Current Drug Targets
Title:Tapping into Mitochondria to Find Novel Targets for Diabetes Complications
Volume: 17 Issue: 12
Author(s): Nicole B. Flemming, Linda A. Gallo, Micheal S. Ward and Josephine M. Forbes
Affiliation:
Keywords: Diabetic complications, mitochondria, nephropathy, networking, oxidative phosphorylation, retinopathy, ROS, superoxide.
Abstract: Mitochondria produce the majority of cellular energy via the “slow burn” of substrates such as glucose, free fatty acids and ketones. In diabetes, altered mitochondrial energetics and substrate utilisation may explain, in part, an organ’s susceptibility to complications. This is particularly evident at sites such as the kidney, heart, neurons and retina, which have high energy demands and oxygen consumption rates to meet functional requirements. Within this review we highlight the recent research implicating mitochondrial dysfunction, with particular focus on the contribution of mitochondrial reactive oxygen species, on the development and progression of diabetes complications. Finally, we discuss the current strategies which are being assessed to combat mitochondrial dysfunction in diabetes complications.
Export Options
About this article
Cite this article as:
Flemming B. Nicole, Gallo A. Linda, Ward S. Micheal and Forbes M. Josephine, Tapping into Mitochondria to Find Novel Targets for Diabetes Complications, Current Drug Targets 2016; 17 (12) . https://dx.doi.org/10.2174/1389450116666150727114410
DOI https://dx.doi.org/10.2174/1389450116666150727114410 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
High-dose Vitamin D Supplementation on Type 1 Diabetes Mellitus Patients: Is there an Improvement in Glycemic Control?
Current Diabetes Reviews Cytokine-Induced Depression: Current Status and Novel Targets for Depression Therapy
CNS & Neurological Disorders - Drug Targets Editorial (Thematic Issue: Advances in the Pharmacokinetics of Natural Bioactive Polyphenols)
Current Drug Metabolism RhoGEFs in Cell Motility: Novel Links Between Rgnef and Focal Adhesion Kinase
Current Molecular Medicine ROCK in CNS: Different Roles of Isoforms and Therapeutic Target for Neurodegenerative Disorders
Current Drug Targets Oxindole Derivatives: Synthesis and Antiglycation Activity
Medicinal Chemistry Searching for Phytoinsulins as Cardiovascular Protector in Metabolic Syndrome
Current Pharmaceutical Design Challenges for the Treatment of Diabetes Mellitus
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) RAAS Inhibition and Renal Protection
Current Pharmaceutical Design Ring Finger Ubiquitin Protein Ligases and Their Implication to the Pathogenesis of Human Diseases
Current Pharmaceutical Design Restoring the Dysfunctional Endothelium
Current Pharmaceutical Design Thienocinnolinone Alkanoic Acid Derivatives as Aldose Reductase Inhibitors
Medicinal Chemistry Editorial [Hot topic: Transgenic Animal Models of Neurodegenerative Diseases (Guest Editor: Stephen D. Skaper)]
CNS & Neurological Disorders - Drug Targets Macronutrient Specific Postprandial Oxidative Stress: Relevance to the Development of Insulin Resistance
Current Diabetes Reviews Why Not to Use the Handgrip Test in the Assessment of Cardiovascular Autonomic Neuropathy Among Patients with Diabetes Mellitus?
Current Vascular Pharmacology Insulin Regulation of PEPCK Gene Expression: A Model for Rapid and Reversible Modulation
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Lactoferrin as a Natural Immune Modulator
Current Pharmaceutical Design Versatile Functions of Heat Shock Factors: It is Not All About Stress
Current Immunology Reviews (Discontinued) Rapid and Solventless Analysis of Polychlorinated Biphenyls in Packaged Milk Using Gas Chromatography
Current Chromatography The Role of AGEs in Cardiovascular Disease
Current Pharmaceutical Design